Abstract
National guidelines for treatment of ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, and hyponatremia have been approved by the Danish Society of Gastroenterology and Hepatology. Ascites develops in approximately 60% of patients with cirrhosis during a 10 year period and is frequently associated with complications that determine the course of the disease and the prognosis. These evidence-based guidelines are divided in two parts and consider definitions, pathophysiology, diagnostic aspects, treatment, and prophylaxis.
MeSH terms
-
Acute Kidney Injury / etiology
-
Acute Kidney Injury / physiopathology
-
Clinical Protocols / standards
-
Contraindications
-
Diuretics* / administration & dosage
-
Diuretics* / adverse effects
-
Evidence-Based Medicine / standards
-
Fluid Therapy* / adverse effects
-
Fluid Therapy* / methods
-
Fluid Therapy* / standards
-
Hepatorenal Syndrome / diagnosis
-
Hepatorenal Syndrome / etiology
-
Hepatorenal Syndrome / metabolism
-
Hepatorenal Syndrome / physiopathology
-
Hepatorenal Syndrome / therapy*
-
Humans
-
Hyponatremia / etiology
-
Hyponatremia / metabolism
-
Hyponatremia / physiopathology
-
Hyponatremia / therapy*
-
Liver Cirrhosis / complications
-
Liver Cirrhosis / physiopathology
-
Lypressin / administration & dosage
-
Lypressin / adverse effects
-
Lypressin / analogs & derivatives*
-
Renal Insufficiency, Chronic / etiology
-
Renal Insufficiency, Chronic / physiopathology
-
Terlipressin
-
Vasoconstrictor Agents / administration & dosage
-
Vasoconstrictor Agents / adverse effects
-
Water-Electrolyte Imbalance / etiology
-
Water-Electrolyte Imbalance / physiopathology
Substances
-
Diuretics
-
Vasoconstrictor Agents
-
Lypressin
-
Terlipressin